⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4642295 | 0.84 | — | — | |
| SCHEMBL4957348 | 0.82 | TSHR (0.47) | — | |
| SCHEMBL163599 | 0.82 | — | — | |
| SCHEMBL4644763 | 0.82 | — | — | |
| SCHEMBL4646847 | 0.82 | — | — | |
| SCHEMBL4643403 | 0.79 | — | — | |
| SCHEMBL328175 | 0.79 | — | — | |
| SCHEMBL328180 | 0.79 | — | — | |
| Chloroacetic Acid SCHEMBL21752872 | 0.76 | CA4 (0.50) | — | |
| SCHEMBL6000096 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1503798-B8 | STABILISED SOLID COMPOSITIONS OF MODIFIED FACTOR VII | NOVO NORDISK HEALTHCARE AG (CH) | 2012-03-14 | — | — | EP | claimed |
| US-20090075895-A1 | Stabilised Solid Composition of Modified Factor VII | NOVO NORDISK A/S (DK) | 2009-03-19 | — | — | US | claimed |
| US-20070049523-A1 | Liquid composition of modified factor VII polypeptides | NOVO NORDISK A/S (DK) | 2007-03-01 | — | — | US | claimed |
| EP-1503798-A1 | STABILISED SOLID COMPOSITIONS OF MODIFIED FACTOR VII | NOVO NORDISK A/S (DK) | 2005-02-09 | — | — | EP | claimed |
| EP-1458407-A1 | LIQUID COMPOSITION OF MODIFIED FACTOR VII POLYPEPTIDES | NOVO NORDISK A/S (DK) | 2004-09-22 | — | — | EP | claimed |
| US-20040043933-A1 | Liquid composition of modified factor VII polypeptides | NOVO NORDISK HEALTHCARE A/G (CH) | 2004-03-04 | — | — | US | claimed |
| US-20040009918-A1 | Stabilised solid compositions of modified factor VII | NOVO NORDISK HEALTHCARE AG (CH) | 2004-01-15 | — | — | US | claimed |
| WO-2003092731-A1 | STABILISED SOLID COMPOSITIONS OF MODIFIED FACTOR VII | NOVO NORDISK A/S (DK) | 2003-11-13 | — | — | WO | claimed |
| WO-2003055511-A1 | LIQUID COMPOSITION OF MODIFIED FACTOR VII POLYPEPTIDES | NOVO NORDISK A/S (DK) | 2003-07-10 | — | — | WO | claimed |
| US-9029695-B2 | Heteroaromatic semiconducting polymers | RAYNERGY TEK INC. (TW) | 2015-05-12 | — | — | US | disclosed |
| US-9029695-B2 | Heteroaromatic semiconducting polymers | RAYNERGY TEK INC. (TW) | 2015-05-12 | — | — | US | disclosed |
| US-20140353628-A1 | Heteroaromatic Semiconducting polymers | RAYNERGY TEK INC. (TW) | 2014-12-04 | — | — | US | disclosed |
| US-20140353628-A1 | Heteroaromatic Semiconducting polymers | RAYNERGY TEK INC. (TW) | 2014-12-04 | — | — | US | disclosed |
| EP-1487928-B1 | FILM-FORMING POLYMER AND ANTIFOULING PAINT | JOTUN AS (NO) | 2008-08-13 | — | — | EP | disclosed |
| WO-2003080747-A1 | FILM-FORMING POLYMER AND ANTIFOULING PAINT | JOTUN AS (NO) | 2003-10-02 | — | — | WO | disclosed |
| WO-2003055511-A1 | LIQUID COMPOSITION OF MODIFIED FACTOR VII POLYPEPTIDES | NOVO NORDISK A/S (DK) | 2003-07-10 | — | — | WO | disclosed |
| EP-0660175-B1 | Control of replenishment during photographic development | STERLING DIAGNOSTIC IMAGING (US) | 2000-03-22 | — | — | EP | disclosed |
| US-5541027-A | Method for determining the proper replenishment for a developing solution | E. I. DU PONT DE NEMOURS AND COMAPNY (US) | 1996-07-30 | — | — | US | disclosed |
| EP-0660175-A2 | Control of replanishment during photographic development | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-06-28 | — | — | EP | disclosed |
| US-4409389-A | Preparation of imidazoles | EASTMAN KODAK COMPANY (US) | 1983-10-11 | — | — | US | disclosed |